Literature DB >> 2998281

Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils.

A K Saha, J N Dowling, K L LaMarco, S Das, A T Remaley, N Olomu, M T Pope, R H Glew.   

Abstract

The high-speed supernatant (100,000 g, 1 h) obtained after centrifuging a suspension of Legionella micdadei that had been freeze-thawed and sonicated contained (i) considerable acid phosphatase activity when assayed using 4-methylumbelliferyl phosphate (MUP) as the substrate, and a factor that blocked superoxide anion production by human neutrophils stimulated with f-Met-Leu-Phe. Chromatography of the extract on a hydroxylapatite column resolved two acids phosphatases (designated ACP1 and ACP2). Subsequent chromatography of ACP2 on a Sephadex G-150 column revealed coincident elution of phosphatase activity and neutrophil blocking activity. When heated at 45 degrees C for various periods of time, the phosphatase activity of the acid phosphatase preparation was lost at the same rate as the ability of the preparation to block superoxide anion production by neutrophils. Furthermore, preincubation of neutrophils and acid phosphatase together in the presence of a heteropolymolybdate complex that inhibits the phosphatase eliminated the effect of the L. micdadei phosphatase on neutrophil superoxide anion production. ACP2 had the following properties: pH optimum, 6.0; Km for MUP, 3.8 mM; isoelectric point, 4.5; substrate specificity, MUP greater than ADP greater than phosphoenolpyruvate greater than phosphothreonine greater than phosphoserine greater than phosphotyrosine; molecular weight (estimated by sucrose density gradient centrifugation and gel filtration chromatography), 71,000-86,000. These results indicate that a cell-associated phosphatase may play a role in the virulence of L. micdadei.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998281     DOI: 10.1016/0003-9861(85)90783-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  29 in total

1.  Novel phospholipase A activity secreted by Legionella species.

Authors:  A Flieger; S Gong; M Faigle; M Deeg; P Bartmann; B Neumeister
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  Legionella pneumophila major acid phosphatase and its role in intracellular infection.

Authors:  V Aragon; S Kurtz; N P Cianciotto
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Purification and characterization of a UDP-glucosyltransferase produced by Legionella pneumophila.

Authors:  Iouri Belyi; Michel R Popoff; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

4.  Cryptosporidium parvum: identification and characterization of an acid phosphatase.

Authors:  María Magdalena Aguirre-García; Pablo C Okhuysen
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

Review 5.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

Review 6.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 7.  Bacterial Virulence Factors: Secreted for Survival.

Authors:  Aditya Kumar Sharma; Neha Dhasmana; Neha Dubey; Nishant Kumar; Aakriti Gangwal; Meetu Gupta; Yogendra Singh
Journal:  Indian J Microbiol       Date:  2016-11-05       Impact factor: 2.461

8.  Outer membrane lipoprotein e (P4) of Haemophilus influenzae is a novel phosphomonoesterase.

Authors:  T J Reilly; D L Chance; A L Smith
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

9.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

10.  AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence.

Authors:  Nrusingh P Mohapatra; Ashwin Balagopal; Shilpa Soni; Larry S Schlesinger; John S Gunn
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.